Cardiologs Holter Platform vs Tempus ECG-Low EF

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Philips (Cardiologs)
VS
by Tempus

AI Verdict

Tool A, the Cardiologs Holter Platform, specializes in cloud-based analysis of Holter ECGs to detect over 20 types of arrhythmias, streamlining long-term cardiac monitoring. In contrast, Tool B, Tempus ECG-Low EF, is an integrated software designed to analyze 12-lead ECGs specifically for signs associated with low left ventricular ejection fraction, aiding in heart failure risk assessment. While both are FDA-cleared cardiology AI tools for ECG analysis, their distinct input types (Holter vs. 12-lead) and primary diagnostic focuses (arrhythmias vs. LVEF) make them complementary rather than direct competitors.

Choose Cardiologs Holter Platform if…

Choose Cardiologs Holter Platform if your practice requires a comprehensive, cloud-based solution for efficient and accurate long-term arrhythmia detection across a diverse patient population. This tool is ideal for streamlining Holter ECG analysis, reducing turnaround times, and integrating seamlessly with existing EMR systems, regardless of the Holter device used.

View Cardiologs Holter Platform →

Choose Tempus ECG-Low EF if…

Choose Tempus ECG-Low EF if your primary goal is to quickly screen for potential low left ventricular ejection fraction (LVEF) in patients aged 40 or older using standard 12-lead ECGs within a clinical diagnostic setting. This AI software is best suited for aiding clinicians in identifying at-risk heart failure patients who may require further evaluation based on a binary output.

View Tempus ECG-Low EF →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Cardiologs Holter Platform Tempus ECG-Low EF
Deployment Cloud Integrates with current ECG platforms and electronic health records (EHRs).
FDA Status Cleared AI-estimated Cleared AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Cardiologs Holter Platform

Tool A offers a cloud-based platform for anytime, anywhere access and significantly reduces Holter analysis time by approximately 42%. Its vendor-neutral compatibility and generation of easy-to-read reports suggest a more streamlined and flexible user experience for comprehensive analysis.

Clinical Value

Tempus ECG-Low EF

While Tool A detects over 20 types of arrhythmias, Tool B provides a novel and high-impact clinical insight by detecting signs associated with low Left Ventricular Ejection Fraction (LVEF u226440%) from a standard 12-lead ECG. This capability aids in identifying patients at risk for heart failure earlier, potentially leading to more timely interventions.

Pricing & Value

Cardiologs Holter Platform

Tool A offers a more transparent and predictable pricing model, stating 'Pay per ECG regardless the number of users.' This allows healthcare facilities to better estimate costs based on their volume of studies. Tool B only states 'contact vendor,' providing no immediate insight into its cost structure.

Enterprise Readiness

Cardiologs Holter Platform

Both tools are FDA cleared, HIPAA compliant, and offer BAAs. However, Tool A explicitly details its cloud-based SaaS deployment, integration with EMR systems (Philips IntelliBridge Enterprise), and secure data hosting on ISO/IEC 27001 certified AWS servers, indicating a more robust and clearly articulated enterprise-grade infrastructure.

Innovation

Tempus ECG-Low EF

While Tool A utilizes deep learning and cloud technology to streamline existing Holter analysis, Tool B's innovation lies in its ability to extract novel and critical information (low LVEF risk) from a standard 12-lead ECG. This represents a more fundamental advancement in diagnostic capability, creating a new screening pathway for heart failure.

Support & Docs

Cardiologs Holter Platform

Tool A provides explicit instructions for accessing technical support through its platform's 'Help' menu and mentions the availability of documentation such as brochures and white papers. Tool B's information does not detail specific support channels or readily available documentation.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Cardiologs Holter Platform Tempus ECG-Low EF
Tool Name Cardiologs Holter Platform Tempus ECG-Low EF
Company Philips France Commercial Tempus AI
Primary Detection Focus Detects over 20 types of arrhythmias Detects signs associated with low left ventricular ejection fraction (LVEF u226440%)
Input ECG Type Holter ECG 12-lead ECG recordings
Target Patient Population/Use Case Streamline cardiac diagnostics for healthcare professionals Patients 40 years or older at risk of heart failure

Videos

Demos, reviews, and walkthroughs featuring Cardiologs Holter Platform and Tempus ECG-Low EF.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

The Cardiologs Holter Platform analyzes Holter ECG recordings to detect arrhythmias. Tempus ECG-Low EF analyzes resting, non-ambulatory 12-lead ECG recordings to detect signs associated with low left ventricular ejection fraction.
The Cardiologs Holter Platform is designed to detect over 20 types of arrhythmias. Tempus ECG-Low EF helps identify patients 40 years or older at risk of heart failure by detecting signs associated with low Left Ventricular Ejection Fraction (LVEF u226440%).
The Cardiologs Holter Platform generates easy-to-read, automatically enriched reports. Tempus ECG-Low EF provides a binary output, indicating either 'Low LVEF Detected' or 'Not Detected'.
The Cardiologs Holter Platform offers vendor-neutral compatibility with multiple Holter devices. Tempus ECG-Low EF analyzes standard 12-lead ECG recordings collected at a healthcare facility.
The Cardiologs Holter Platform aims to reduce Holter analysis time by approximately 42% and streamline cardiac diagnostics for arrhythmia assessment. Tempus ECG-Low EF aids clinicians in identifying patients at risk of heart failure by flagging potential low LVEF, prompting further evaluation.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.